Peripheral Arterial Disease Trial, Recruiting (NCT06992752)

Peripheral Arterial Disease Trial, Recruiting NCT06992752 Sponsor: Hacettepe University Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06992752 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing to take part in the study
You have been diagnosed with Thoracic Outlet Syndrome (TOS) by a chest/thoracic surgeon
You are between 18 and 65 years old
You have been experiencing pain for more than 6 months

Who may not be able to join:

You have had surgery on your spine or chest area in the past, for any reason
You have had a serious injury to your neck caused by trauma or an accident
You are severely obese, with a BMI over 40 (confirm with trial site)
You have known physical abnormalities affecting your rib cage or spine
You have been exposed to certain industrial hazards through your work (confirm with trial site)
You have serious existing health conditions, including neurological, muscle, heart, lung, psychiatric, or bone and joint disorders, as well as diabetes or cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Melda Sağlam, Professor, Hacettepe University

Phone: +903123052525

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06992752

Sponsor: Hacettepe University

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: +903123052525

More information: https://clinicaltrials.gov/study/NCT06992752

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing to take part in the study
You have been diagnosed with Thoracic Outlet Syndrome (TOS) by a chest/thoracic surgeon
You are between 18 and 65 years old
You have been experiencing pain for more than 6 months

Who may not be able to join:

You have had surgery on your spine or chest area in the past, for any reason
You have had a serious injury to your neck caused by trauma or an accident
You are severely obese, with a BMI over 40 (confirm with trial site)
You have known physical abnormalities affecting your rib cage or spine
You have been exposed to certain industrial hazards through your work (confirm with trial site)
You have serious existing health conditions, including neurological, muscle, heart, lung, psychiatric, or bone and joint disorders, as well as diabetes or cancer

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hacettepe University

Registry

ClinicalTrials.gov

Start date

2 February 2025

Est. completion

2 September 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Nijmegen Questionnaire; End tidal CO2; Manual Assessment of Respiratory Motion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov